Product information
From Health Canada
No match found
No other product was found with the same active ingredient group.
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Cancelled Post Market
Current status date:
2010-11-12
Original market date: See footnote 1
2002-07-15
Product name:
TARKA
DIN:
02238096
Product Monograph/Veterinary Labelling:
Date:
2007-02-13
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
ABBOTT LABORATORIES, LIMITED
8401 Trans-Canada Highway
Saint-Laurent
Quebec
Canada
H4S 1Z1
Class:
Human
Dosage form(s):
Tablet (Extended-Release)
Route(s) of administration:
Oral
Number of active ingredient(s):
2
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS): See footnote 3
24:32.04 , 24:28.92
Anatomical Therapeutic Chemical (ATC): See footnote 4
C09BB10 TRANDOLAPRIL AND VERAPAMIL
Active ingredient group (AIG) number:See footnote5
0233661002
| Active ingredient(s) | Strength |
|---|---|
| TRANDOLAPRIL | 2 MG |
| VERAPAMIL HYDROCHLORIDE | 180 MG |